Almukhadeb Eman
Dermatology, College of Medicine, King Saud University, Riyadh, SAU.
Cureus. 2021 Jul 30;13(7):e16762. doi: 10.7759/cureus.16762. eCollection 2021 Jul.
Desloratadine is a second-generation H1-type antihistamine that is widely prescribed for multiple indications including allergic rhinitis and urticaria. It is well-tolerated and is not known to cause cutaneous side effects including fixed drug eruption (FDE). In this report, a case of recurrent fixed drug eruption induced by desloratadine is reported.